ELV Stock Analysis
EL
Avoid
Based on Eyestock quantitative analysis, ELV`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Market cap $B
126.03
Dividend yield
1.15 %
Shares outstanding
237.46 B
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana and currently employs 102,300 full-time employees. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm supports consumers, families, and communities across the entire care journey - connecting them to the care, support, and resources they need to lead healthier lives. The firm operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. The Commercial & Specialty Business segment offers plans and services to the Individual, Group risk-based, Group fee-based and BlueCard members. The Government Business segment includes its Medicare and Medicaid businesses, National Government Services and services provided to the federal government in connection with the Federal Employees Health Benefits (FEHB) Program business. The CarelonRx segment includes its pharmacy benefit management (PBM) business. CarelonRx markets and offers PBM services to its affiliated health plan customers. The Other segment includes the Company's Carelon Services.